# Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects

> **NCT05508204** · PHASE1 · COMPLETED · sponsor: **Chinook Therapeutics, Inc.** · enrollment: 36 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** BION-1301

## Key facts

- **NCT ID:** NCT05508204
- **Lead sponsor:** Chinook Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-19
- **Primary completion:** 2022-12-16
- **Final completion:** 2022-12-16
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05508204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05508204, "Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05508204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*